Hematology

EMJ spoke with Claire Harrison about receiving the EHA 2026 Lifetime Achievement Award, her pioneering work in MPNs.

Join leading myeloproliferative neoplasm (MPN) experts Claire Harrison, Francesca Palandri, and Prithviraj Bose as they discuss the most…

Cecilia Karlström speaks about the latest developments in immune thrombocytopenia (ITP) and thrombotic thrombocytopenic purpura (TTP).

Nicola Conran shares insights from EHA 2026 on emerging therapies, gene editing, inflammation, and the evolving treatment landscape in sickle cell disease.

This lower-risk myelodysplastic syndromes symposium provided an overview of emerging data from pivotal trials and real-world evidence…

This symposium from European Hematology Association (EHA) 2026 in Stockholm, Sweden, chaired by Gail Roboz, will explore three key…

Care in this field is transforming rapidly. To optimise patient outcomes and navigate evolving treatment pathways, clinicians need a clear…

Roberto Mina shares insights from EHA 2026 on MonumenTAL-3, MajesTEC-9, CEPHEUS, and the evolving multiple myeloma treatment landscape.